Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture.
Bayer is an innovation company with a more than 150-year history. Our scientific successes are intended to help improve people’s lives.
With our distinctive knowledge of people, animals and plants, we focus on the areas of health care and nutrition.
Read more about our economic, ecological and social challenges and opportunities.
This area provides news, videos and publications, as well as overviews of social media channels and mobile apps of the Bayer Group.
We want to create value for our shareholders through innovation, growth and high earning power.
Looking for a job in an innovative company? Learn more about Bayer and the opportunities available.
59.19 % of the statutory capital of Bayer AG was present at the Annual Stockholders’ Meeting 2017. This includes the participants of the Annual Stockholders Meeting as well as the votes cast by postal voting.
Distribution of the profit
Ratification of the actions of the Board of Management
Ratification of the actions of the Supervisory Board
Supervisory Board elections
Dr. Paul Achleitner
Dr. Norbert W. Bischofberger
Colleen A. Goggins
Dr. Klaus Sturany
Amendment of the compensation of the Supervisory Board
Approval of the control agreement with Bayer CropScience AG
Election of the Auditor (Full-year, Half-year and Q3 2017; Q1 2018)